CSIMarket
 


Envista Holdings Corporation  (NVST)
Other Ticker:  
 
 

NVST's Free Cash Flow Growth by Quarter and Year

Envista Holdings's Free Cash Flow results by quarter and year




NVST Free Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 102.00 110.30 136.00 193.40
III Quarter September 95.50 46.70 88.30 148.10
II Quarter June 75.10 22.20 120.70 4.70
I Quarter March 3.10 3.50 16.60 -62.30
FY   275.70 182.70 361.60 283.90



NVST Free Cash Flow fourth quarter 2023 Y/Y Growth Comment
Envista Holdings Corporation reported decrease in Free Cash Flow in the fourth quarter 2023 by -7.52% to $ 102.00 millions, from the same quarter in 2022.
The decrease in the fourth quarter 2023 Envista Holdings Corporation's Free Cash Flow compares unfavorably to the Company's average Free Cash Flow increase of 15.29%.

Looking into fourth quarter 2023 results within Medical Equipment & Supplies industry 11 other companies have achieved higher Free Cash Flow growth. While Envista Holdings Corporation' s Free Cash Flow decline of -7.52% ranks overall at the positon no. 459 in the fourth quarter 2023.




NVST Free Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December -7.52 % -18.9 % -29.68 % 3.42 %
III Quarter September 104.5 % -47.11 % -40.38 % -29.64 %
II Quarter June 238.29 % -81.61 % 2468.09 % -
I Quarter March -11.43 % -78.92 % - -
FY   50.9 % -49.47 % 27.37 % -28.58 %

Financial Statements
Envista Holdings's fourth quarter 2023 Free Cash Flow $ 102.00 millions NVST's Income Statement
Envista Holdings's fourth quarter 2022 Free Cash Flow $ 110.30 millions Quarterly NVST's Income Statement
New: More NVST's historic Free Cash Flow Growth >>


NVST Free Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December 6.81 % 136.19 % 54.02 % 30.59 %
III Quarter September 27.16 % 110.36 % -26.84 % 3051.06 %
II Quarter June 2322.58 % 534.29 % 627.11 % -
I Quarter March -97.19 % -97.43 % -91.42 % -
FY (Year on Year)   50.9 % -49.47 % 27.37 % -28.58 %




Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #12
Healthcare Sector #35
Overall #459

Free Cash Flow Y/Y Growth Statistics
High Average Low
191.9 % 15.29 % -42.29 %
(Dec 31 2020)   (Sep 30 2022)
Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #12
Healthcare Sector #35
Overall #459
Free Cash Flow Y/Y Growth Statistics
High Average Low
191.9 % 15.29 % -42.29 %
(Dec 31 2020)   (Sep 30 2022)

Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Envista Holdings's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
3051.06 % 438.41 % -97.43 %
(Oct 02 2020)  


NVST's IV. Quarter Q/Q Free Cash Flow Comment
Envista Holdings Corporation achieved in the IV. Quarter 2023 below company average Free Cash Flow increase of 6.81% quarter on quarter, to $ 102.00 millions.

Within Medical Equipment & Supplies industry 7 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Envista Holdings's Free Cash Flow growth quarter on quarter, overall rank is 246.


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #23
Overall #246
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #23
Overall #246
Free Cash Flow Q/Q Growth Statistics
High Average Low
3051.06 % 438.41 % -97.43 %
(Oct 02 2020)  


NVST's IV. Quarter Q/Q Free Cash Flow Comment
Envista Holdings Corporation achieved in the IV. Quarter 2023 below company average Free Cash Flow increase of 6.81% quarter on quarter, to $ 102.00 millions.

Within Medical Equipment & Supplies industry 7 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Envista Holdings's Free Cash Flow growth quarter on quarter, overall rank is 246.


Envista Holdings's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 29 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Free Cash Flow 12 Months Ending $ 333.90 $ 350.90 $ 310.60 $ 255.70 $ 258.40
Y / Y Free Cash Flow Growth (TTM) 29.22 % 27.18 % 0.81 % -38.34 % -37.93 %
Year on Year Free Cash Flow Growth Overall Ranking # 565 # 2132 # 1688 # 1281 # 601
Seqeuential Free Cash Flow Change (TTM) -4.84 % 12.97 % 21.47 % -1.04 % -6.34 %
Seq. Free Cash Flow Growth (TTM) Overall Ranking # 459 # 1661 # 1514 # 1285 # 1210




Cumulative Free Cash Flow growth Comment
Envista Holdings saw improvement in Free Cash Flow growth trend, posting cumulative 12 months Free Cash Flow growth of 29.22% year on year, to $ 334 millions if the fiscal year would have ended in Dec 31 2023.
Envista Holdings's trailing twelve months Free Cash Flow growth was higher than company's average 15.29% and higher than 27.18% growth in Sep 29 2023.

In the Healthcare sector 44 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 565, from total ranking in previous quarter at 2132.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
191.9 %
15.29 %
-42.29 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 12
Healthcare Sector # 45
Overall # 565

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
191.9 %
15.29 %
-42.29 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 35
S&P 500 # 459
Cumulative Free Cash Flow growth Comment
Envista Holdings saw improvement in Free Cash Flow growth trend, posting cumulative 12 months Free Cash Flow growth of 29.22% year on year, to $ 334 millions if the fiscal year would have ended in Dec 31 2023.
Envista Holdings's trailing twelve months Free Cash Flow growth was higher than company's average 15.29% and higher than 27.18% growth in Sep 29 2023.

In the Healthcare sector 44 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 565, from total ranking in previous quarter at 2132.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
191.9 %
15.29 %
-42.29 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 12
Healthcare Sector # 45
Overall # 565

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
191.9 %
15.29 %
-42.29 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 35
S&P 500 # 459




Other Free Cash Flow Growth
Medical Equipment & Supplies Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
NVST's Free Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for NVST's Competitors
Free Cash Flow Growth for Envista Holdings's Suppliers
Free Cash Flow Growth for NVST's Customers

You may also want to know
NVST's Annual Growth Rates NVST's Profitability Ratios NVST's Asset Turnover Ratio NVST's Dividend Growth
NVST's Roe NVST's Valuation Ratios NVST's Financial Strength Ratios NVST's Dividend Payout Ratio
NVST's Roa NVST's Inventory Turnover Ratio NVST's Growth Rates NVST's Dividend Comparisons



Companies with similar Free Cash Flow increase for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Dec 31 2023
Sanofi-2.55%$ -2.546 millions
Inmode Ltd -2.62%$ -2.617 millions
Charles River Laboratories International inc -5.88%$ -5.884 millions
Mettler toledo International Inc -7.29%$ -7.291 millions
Envista Holdings Corporation-7.52%$ -7.525 millions
Bio rad Laboratories Inc -10.37%$ -10.366 millions
Inspire Medical Systems inc -10.39%$ -10.390 millions
Insulet Corporation-10.85%$ -10.848 millions
Laboratory Corporation Of America Holdings-11.32%$ -11.322 millions
Hologic Inc-13.18%$ -13.181 millions
Neurocrine Biosciences Inc -13.64%$ -13.636 millions
Gilead Sciences Inc -15.50%$ -15.504 millions
Bausch Health Companies Inc -17.89%$ -17.895 millions
Koru Medical Systems Inc-17.93%$ -17.932 millions
Progyny Inc -26.90%$ -26.900 millions
Ufp Technologies Inc -29.00%$ -28.997 millions
Enhabit Inc -29.27%$ -29.268 millions
Integra Lifesciences Holdings Corp-31.15%$ -31.153 millions
Cryoport inc -32.07%$ -32.074 millions
Qiagen N v -35.76%$ -35.764 millions
Abbvie inc -36.01%$ -36.012 millions
Regeneron Pharmaceuticals Inc -36.64%$ -36.642 millions
Pfizer Inc-38.94%$ -38.942 millions
Axonics Inc -39.81%$ -39.805 millions
Warby Parker Inc -42.68%$ -42.678 millions
Catalent Inc -47.66%$ -47.664 millions
Intuitive Surgical Inc -47.86%$ -47.865 millions
Incyte Corporation-47.92%$ -47.921 millions
Jazz Pharmaceuticals Plc-51.07%$ -51.066 millions
Edwards Lifesciences Corporation-51.70%$ -51.697 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com